Answers are grounded in this paper and cite their sources.
Patients were selected based on the following criteria: Inclusion criteria as follows:• 18-45 years of age.• Posterior teeth.• Irreversible pulpitis.• Pain score ranging from moderate to severe.4-10 • Informed consent was obtained.Exclusion criteria are as follows:• <18 years and >45 years.• Allergic to NSAIDs. IntroductIonDiclofenac is the most commonly given nonsteroidal anti-inflammatory drug (NSAID), which has anti-inflammatory, analgesic, and antipyretic properties.Recently, diclofenac transdermal patches have been developed as an innovative topical drug delivery system, offering the advantage of using sustained drug delivery 5 with fewer incidences of systemic adverse effects due to low plasma concentrations.The study was done to measure postoperative endodontic pain using oral and transdermal diclofenac transdermal patches. ratIonaleThe purpose of this randomized clinical trial was to investigate the pretreatment and posttreatment analgesia effect of the tab.Diclofenac and the transdermal patch of diclofenac for controlling postoperative pain in patients with irreversible pulpitis cases. objectIveEvaluate postoperative endodontic pain after 24 hours.
No takes yet. Share an insight, caveat, or question.
Murugan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: